• N&PD Moderators: Skorpio | thegreenhand

Ketamine salts solubility

Status
Not open for further replies.
1-(3,4-dimethylphenyl)-2-ethylaminopropane.png


ELEANOR
1-(3,4-dimethylphenyl)-2-ethylaminopropane
 
Yes, because it won't be the same procedure as fenfluramine synthesis in the slightest manner. One simply adjusts for MW. Even the solubilities of the precursors and intermediates only deviates by a gnats-chuff. Why not go mad and make the chiral compound?
 
The fenfluramine synthesis is rather odd. I would take a Shulgin-esque approach for ELEANOR.

Why not make the chiral compound? That would give the chiral compound. These next 2 would be the bromopropionate Friedels-Kraft route.

1-(4-methylphenyl)-1-oxo-2-ethylaminopropane.png


JUNE_BUG
1-(4-methylphenyl)-1-oxo-2-ethylaminopropane

Basically it's just N-ethyl-4-MMC / mephedrone.

1-(3,4-dimethylphenyl)-1-oxo-2-methylaminopropane.png


XYLODRONE
1-(3,4-dimethylphenyl)-1-oxo-2-methylaminopropane

Looks good a moi.
 
Last edited:
Friedel–Crafts acylation. Fine if you think working with bromine is a good move. It's cheap crap made my semi-skilled Chinese.

4-methylethcathinone (4-MEC) is already known as NRG-2.

3,4-dimethylethcathinone (3,4-MEC) is already known as NRG-7.

Wow, that took a 30 second search of Wikipedia...
 
And Visions Of

1-(2-(methylthio)-3,4-dimethylphenyl)-2-aminopropane.png


SUGAR_PLUMES
1-(2-(methylthio)-3,4-dimethylphenyl)-2-aminopropane

Danced In Their Heads.
 
Essential Oil Trifecta:

3,4-methylenedioxy-1-allylbenzene.png


SAFROLE
3,4-methylenedioxy-1-allylbenzene

3,4-methylenedioxy-5-methoxy-1-allylbenzene.png


NUTMEG
3,4-methylenedioxy-5-methoxy-1-allylbenzene

1-allyl-3,4,5-trimethoxybenzene.png


ELEMI
1-allyl-3,4,5-trimethoxybenzene
 
Last edited:
I'm not making anything, but the precursor for that one is 3,4-dimethyl-2-methylthiobenzaldehyde, which may require a custom synth.
 
OK - how are you making the above?
He is the kind of chemist I like and respect the least - the infamous paper chemist. A paper chemist can know anything from a little to a lot about chemistry, and might even be a competent researcher or teacher. But when it comes to any actual practical chemistry they usually lack any experience, and left to their own devices in a real lab they are more likely to make a tremendous mess, damage equipment, or even cause injury than achieve even partial results attempting to carry out any sort of synthesis unsupervised.
I met one before, a new hire at my job. He had a Ph.D and all sorts of accolades and awards. We asked him to make a few hundred grams of a known compound that had a simple synthesis from circa 1900 using common and cheap reagents, and a trivial purification method. A few weeks later he had managed to start a fire attempting a synthesis, but eventually produced perhaps 0.5g of compound or so.
The final straw, I gave him a complex terpene mixture to seperate with column chromatography. He dutifully did so, but neglected to actually analyse the fractions collected. When he gave me back a tray of 50 vials or so, I was dismayed to see that the first 30 contained only solvent and the next 20 - the very least polar and first eluting compound. He had simply collected 50 fractions, tested none of them in any way, and based on nothing at all, decided that was good enough.
He did not stay employed for long after that one...
 
sekio,

You Are Largely Correct. I Have A Degree In Chemistry, But I Am Basically Self Taught. I Had A Job Once In Chemistry. It Ended Badly. But Proposing Lead Structures I Am Good At, Paper Chemist Or Not.
 
Maybe you ought to invest in some appropriate software? Older versions of ChemOffice turn up on Ebay from time to time for about £100.

Newer versions are all downloads and are designed to send you to Elsevier to BUY the references whereas those who know simply use Sci Hub.

If nothing else, it provides pretty pictures and provides for things like GMEC calculations so you can see what the chemical will look like 'in nature' although to be fair, I know a lot of compounds bind in a near-GMEC conformation.
 
ID Time add. Title Series Author(s) Publisher Year PagesLanguage
Alcoholism: Clinical and Experimental Research vol. 29 iss. 8 pp.1390—1401
Selective GABAAα5 Benzodiazepine Inverse Agonist Antagonizes the Neurobehavioral Actions of Alcohol
DOI: 10.1097/01.alc.0000175073.94575.86 a a
Jason B. Cook; Katrina L. Foster; William J. A. Eiler II; Peter F. McKay; James Woods II; Scott C. Harvey;[...]2005 AugustEnglish
Journal of Vascular Surgery vol. 14 iss. 2 pp.147—151
Thrombomodulin activity on human saphenous vein grafts prepared for coronary artery bypass
DOI: 10.1067/mva.1991.28730 a a
Cook, James M.; Cook, Christine D.; Marlar, Richard; Solis, Maurice M.; Fink, Lou; Eidt, John F.1991 AugustEnglish
Phytochemistry vol. 12 iss. 6 pp.1467—1474
Further alkaloids of Alstonia muelleriana
DOI: 10.1016/0031-9422(73)80586-2 a a
David E. Burke; Gloria A. Cook; James M. Cook; Kathleen G. Haller; Harvey A. Lazar; Philip W. Le Quesne1973 JuneEnglish
Psychopharmacology vol. 187 iss. 3 pp.321—330
Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAAreceptor subtypes
DOI: 10.1007/s00213-006-0431-2 a a
Angela N. Duke; Donna M. Platt; James M. Cook; Shengming Huang; Wenyuan Yin; Bruce A. Mattingly; James K. Rowlett2006 June 17English
Psychopharmacology vol. 203 iss. 3 pp.539—546
Contribution of α1 subunit-containing γ-aminobutyric acidA(GABAA) receptors to motor-impairing effects of benzodiazepines in squirrel monkeys
DOI: 10.1007/s00213-008-1401-7 a a
Stephanie C. Licata; Donna M. Platt; James M. Cook; Michael L. Van Linn; James K. Rowlett2008 November 25English
Pharmacology Biochemistry and Behavior vol. 24 iss. 4 pp.963—965
Differential antagonism of diazepam-induced loss of the righting response
DOI: 10.1016/0091-3057(86)90443-0 a a
Jeffrey M. Witkin; James E. Barrett; James M. Cook; Paul Larscheid1986 AprilEnglish
European Journal of Pharmacology vol. 106 iss. 3 pp.585—591
Cerebrovascular and cerebral metabolic effects of clurazepam and a benzodiazepine antagonist, 3-hydroxymethyl-β-carboline
DOI: 10.1016/0014-2999(84)90062-1 a a
William E. Hoffman; James M. Feld; Paul Larscheid; James M. Cook; Ronald F. Albrecht; David J. Miletich1984 NovemberEnglish
Neuropharmacology vol. 58 iss. 2 pp.357—364
Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): Role of GABAA receptor subtypes
DOI: 10.1016/j.neuropharm.2009.10.004 a a
Stephanie C. Licata; Donna M. Platt; Daniela Rüedi-Bettschen; John R. Atack; Gerard R. Dawson; Michael L. Van Linn;[...]2010 FebruaryEnglish
Neuropharmacology vol. 59 iss. 7-8 pp.612—618
Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure
DOI: 10.1016/j.neuropharm.2010.08.011 a a
Bradford D. Fischer; Stephanie C. Licata; Rahul V. Edwankar; Zhi-Jian Wang; Shengming Huang; Xiaohui He;[...]2010 DecemberEnglish
Bioorganic & Medicinal Chemistry vol. 16 iss. 19 pp.8853—8862
A study of the structure–activity relationship of GABAA–benzodiazepine receptor bivalent ligands by conformational analysis with low temperature NMR and X-ray analysis
DOI: 10.1016/j.bmc.2008.08.072 a a
Dongmei Han; F. Holger Försterling; Xiaoyan Li; Jeffrey R. Deschamps; Damon Parrish; Hui Cao; Sundari Rallapalli;[...]2008 OctoberEnglish
Tetrahedron vol. 47 iss. 23 pp.3665—3710
General approach for the synthesis of polyquinenes via the Weiss reaction
DOI: 10.1016/s0040-4020(01)80896-6 a a
Ashok K. Gupta; Xiaoyong Fu; James P. Snydert; James M. Cook1991French;English;German
Tetrahedron Letters vol. 17 iss. 50 pp.4549—4552
Reactions of dicarbonyl compounds with dimethyl β-ketoglutarate V. Simple synthesis of tricyclo [6.3.0.01,5] Undecane-3, 7, 9-trione, a novel cyclopentanoid compound
DOI: 10.1016/s0040-4039(00)93928-5 a a
James Oehldrich; James M. Cook; Ulrich Weiss1976French;German;English
Psychopharmacology vol. 161 iss. 2 pp.180—188
Role of GABAA/benzodiazepine receptors containing α1and α5subunits in the discriminative stimulus effects of triazolam in squirrel monkeys
DOI: 10.1007/s00213-002-1037-y a a
Snjezana Lelas; James K. Rowlett; Roger D. Spealman; James M. Cook; Chunrong Ma; Xiaoyan Li; Wenyuan Yin2002 May 01English
Psychopharmacology vol. 165 iss. 3 pp.209—215
Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABAA/α1receptors
DOI: 10.1007/s00213-002-1275-z a a
James K. Rowlett; Roger D. Spealman; Snjezana Lelas; James M. Cook; Wenyuan Yin2003 JanuaryEnglish
Evolution vol. 63 iss. 4 pp.854—869
EXTREME HOST PLANT CONSERVATISM DURING AT LEAST 20 MILLION YEARS OF HOST PLANT PURSUIT BY OAK GALLWASPS
DOI: 10.1111/j.1558-5646.2008.00604.x a a
Graham N. Stone; Antonio Hernandez-Lopez; James A. Nicholls; Erica Di Pierro; Juli Pujade-Villar; George Melika;[...]2009 AprilEnglish
Bioorganic & Medicinal Chemistry vol. 21 iss. 1 pp.93—101
Search for α3β2/3γ2 subtype selective ligands that are stable on human liver microsomes
DOI: 10.1016/j.bmc.2012.10.057 a a
Ojas A. Namjoshi; Zhi-jian Wang; Sundari K. Rallapalli; Edward Merle Johnson Jr.; Yun-Teng Johnson; Hanna Ng;[...]2013 JanuaryEnglish
Evolution vol. 63 iss. 4 pp.854—869
Extreme Host Plant Conservatism during at Least 20 Million Years of Host Plant Pursuit by Oak Gallwasps
DOI: 10.2307/25483638 a a
Graham N. Stone, Antonio Hernandez-Lopez, James A. Nicholls, Erica di Pierro, Juli Pujade-Villar, George Melika and James M. Cook2009 AprilEnglish
Phytotherapy Research vol. 24 iss. 9 pp.1309—1316
Behavioural characterization of four endemic Stachys taxa
DOI: 10.1002/ptr.3106 a a
Miroslav M. Savić; Jelena M. Kukić; Renée J. Grayer; Marija M. Milinković; Petar D. Marin; Jovana Divljaković;[...]2010 August 19English
Bioorganic & Medicinal Chemistry vol. 16 iss. 8 pp.4626—4651
Synthesis and structure–activity relationship studies on tryprostatin A, an inhibitor of breast cancer resistance protein
DOI: 10.1016/j.bmc.2008.02.050 a a
Hiteshkumar D. Jain; Chunchun Zhang; Shuo Zhou; Hao Zhou; Jun Ma; Xiaoxiang Liu; Xuebin Liao; Amy M. Deveau;[...]2008 AprilEnglish
Bioorganic & Medicinal Chemistry vol. 18 iss. 12 pp.4178—4186
A new class of potential anti-tuberculosis agents: Synthesis and preliminary evaluation of novel acrylic acid ethyl ester derivatives
DOI: 10.1016/j.bmc.2010.05.016 a a
M. Shahjahan Kabir; Ojas A. Namjoshi; Ranjit Verma; Rebecca Polanowski; Sarah M. Krueger; David Sherman;[...]2010 June 15English
Bioorganic & Medicinal Chemistry Letters vol. 18 iss. 21 pp.5745—5749
New classes of Gram-positive selective antibacterials: Inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis
DOI: 10.1016/j.bmcl.2008.09.085 a a
M. Shahjahan Kabir; Kathleen Engelbrecht; Rebecca Polanowski; Sarah M. Krueger; Rachel Ignasiak; Marc Rott;[...]2008 NovemberEnglish
Progress in Neuro-Psychopharmacology and Biological Psychiatry vol. 34 iss. 2 pp.376—386
Novel positive allosteric modulators of GABAA receptors: Do subtle differences in activity at α1 plus α5 versus α2 plus α3 subunits account for dissimilarities in behavioral effects in rats?
DOI: 10.1016/j.pnpbp.2010.01.004 a a
Miroslav M. Savić; Samarpan Majumder; Shengming Huang; Rahul V. Edwankar; Roman Furtmüller; Srđan Joksimović;[...]2010 MarchEnglish
ChemInform vol. 30 iss. 21 pp.no—no
ChemInform Abstract: Extension of the Tandem Pauson—Khand Reaction to [5.6.6.5]Tetracycles: A Unique Entry into cis-Fused Decalins.
DOI: 10.1002/chin.199921051 a a
Michelle M. Bruendl; Scott G. Van Ornum; Tze-Ming Chan; James M. Cook2010 June 15
ChemInform vol. 31 iss. 29 pp.no—no
ChemInform Abstract: Utility of the Tandem Pauson—Khand Reaction in the Construction of Tetracycles.
DOI: 10.1002/chin.200029035 a a
Scott G. Van Ornum; Michelle M. Bruendl; Hui Cao; Mundala Reddy; Desiree S. Grubisha; Dennis W. Bennett;[...]2010 June 07
ChemInform vol. 38 iss. 21 pp.0—0
First Enantiospecific Total Synthesis of the Important Biogenetic Intermediates, (+)-Polyneuridine(Ia) and (+)-Polyneuridine Aldehyde(IIa), as well as 16-Epi-vellosimine (IIb) and Macusine A (Ib).
DOI: 10.1002/chin.200721177 a a
Wenyuan Yin; Jun Ma; Felix M. Rivas; James M. Cook2007 May 22

Now of course we went a step further an carried a proper human study. Pyeyzolam (selective a5) and Zolpidem (selective a1) strongly suggest that all of the positive subjective effects of alcohol are mediated by the a5 subunit whereas the negative effects are mediated by the a1 subunit. Anyone familiar with Zoplidem will recognise that it does has so nasty psychological side-effects such as loss of executive control, retrograde amnesia, mood lability and so forth.

The few who have sampled pyeyzolam will recognize that huge difference in subjective effects. One can get roughly 2 bottles of wine drunk inside 30 minutes and yet not fall asleep not think or do anything inappropriate, stupid or harmful AND the euphoria is cleaner. I know memory-loss was not an issue. Of course, it MAY have some re-enforcing effects but it totally stopped cravings in alcohol dependant subjects.

So don't expect to see it as a street drug, expect it as a medicine to treat alcoholism and maybe, in the fullness of time, as an alcohol alternative.
 
The problem is, ergot doesn't make LSA.
Supposedly, there is at least one highly valued claviceps paspali mutant that produces direct LA. Was also told it yields 3g of LA per liter of culture every 10 days.

I actually have a bioreactor but never tried to culture anything yet.


How are you going to isolate workable amounts of LSA anyway? Attempting to do chemistry on crude mixtures is a recipe for frustration.
It cant be that difficult? Most natural products just require specific extraction and purification protocols. I employ a ghetto version of flash chromatography similar to CRC in cannabis you just gotta find where your target molecule elutes.. but alot of the pigments are relatively polar and so will stick to the media.
Haven't tried it with morning glories, but it does wonders on other natural products
 
What I Learned From My Chemical Experimentation:

(1l Being High Makes Other People Jealous.
(2) Don't Take 4-oxonium-amphetamine.
 
If I may say so, being high only makes a minority of people jealous. Nobody I KNOW would be jealous.

Don't know of the second item.

Start with something legal and simple. p-F ethylamphetamine isn't controlled in most places, p-F P2P is commercially available and adapting this patent is quite possibly the single, simplest route. https://patents.google.com/patent/US4536518A/en
 
Last edited:
I would just get caught if I tried to make drugs. The problem isn't that I'm too stupid to learn lab chemistry, it is that I have never really been taught.
 
Status
Not open for further replies.
Top